APO Research

APO RESEARCH · REPORT

Colchicine

Selected research

Market Structure

Global Colchicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Colchicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Colchicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Colchicine include Yunnan Plant Medicine, Xishuangbanna Pharmaceutical, Takeda Pharmaceuticals, Tonghua Limin, Kunming Pharmaceutical, Beijing Jialin Pharmaceutical, Yunnan Shan State, Wockhardt and West-Ward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Colchicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Colchicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Colchicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Colchicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Colchicine Segment by Company

Yunnan Plant Medicine

Xishuangbanna Pharmaceutical

Takeda Pharmaceuticals

Tonghua Limin

Kunming Pharmaceutical

Beijing Jialin Pharmaceutical

Yunnan Shan State

Wockhardt

West-Ward

Rhea Pharmaceutical

Prasco

Odan Laboratories

Medinova

Hikma

Guangdong Pedi

Excellium Pharmaceutical

Cipla

Colchicine Segment by Type

Tablet

Oral Solution

Colchicine Segment by Application

Acute Gout

Chronic Gout

Other Conditions

Colchicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colchicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Colchicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colchicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Colchicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Colchicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Colchicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Colchicine Industry Trends Table 2. Colchicine Industry Drivers Table 3. Colchicine Industry Opportunities and Challenges Table 4. Colchicine Industry Restraints Table 5. Global Colchicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Colchicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Colchicine Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Colchicine Sales Market Share by Manufacturers Table 9. Global Colchicine Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Colchicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Colchicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Colchicine Manufacturers, Product Type & Application Table 13. Global Colchicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Colchicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Oral Solution Table 18. Global Colchicine Sales by Type 2021 VS 2025 VS 2032 (tons) Table 19. Global Colchicine Sales by Type (2021-2026) & (tons) Table 20. Global Colchicine Sales by Type (2027-2032) & (tons) Table 21. Global Colchicine Sales Market Share by Type (2021-2026) Table 22. Global Colchicine Sales Market Share by Type (2027-2032) Table 23. Global Colchicine Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 24. Global Colchicine Revenue by Type (2021-2026) & (tons) Table 25. Global Colchicine Revenue by Type (2027-2032) & (tons) Table 26. Global Colchicine Revenue Market Share by Type (2021-2026) Table 27. Global Colchicine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Acute Gout Table 29. Major Manufacturers of Chronic Gout Table 30. Major Manufacturers of Other Conditions Table 31. Global Colchicine Sales by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Colchicine Sales by Application (2021-2026) & (tons) Table 33. Global Colchicine Sales by Application (2027-2032) & (tons) Table 34. Global Colchicine Sales Market Share by Application (2021-2026) Table 35. Global Colchicine Sales Market Share by Application (2027-2032) Table 36. Global Colchicine Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 37. Global Colchicine Revenue by Application (2021-2026) & (tons) Table 38. Global Colchicine Revenue by Application (2027-2032) & (tons) Table 39. Global Colchicine Revenue Market Share by Application (2021-2026) Table 40. Global Colchicine Revenue Market Share by Application (2027-2032) Table 41. Global Colchicine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Colchicine Sales by Region (2021-2026) & (tons) Table 43. Global Colchicine Sales Market Share by Region (2021-2026) Table 44. Global Colchicine Sales Forecasted by Region (2027-2032) & (tons) Table 45. Global Colchicine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 47. North America Colchicine Sales by Country (2021-2026) & (tons) Table 48. North America Colchicine Sales by Country (2027-2032) & (tons) Table 49. Europe Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 50. Europe Colchicine Sales by Country (2021-2026) & (tons) Table 51. Europe Colchicine Sales by Country (2027-2032) & (tons) Table 52. Asia Pacific Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 53. Asia Pacific Colchicine Sales by Country (2021-2026) & (tons) Table 54. Asia Pacific Colchicine Sales by Country (2027-2032) & (tons) Table 55. South America, Middle East and Africa Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 56. South America, Middle East and Africa Colchicine Sales by Country (2021-2026) & (tons) Table 57. South America, Middle East and Africa Colchicine Sales by Country (2027-2032) & (tons) Table 58. Global Colchicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Colchicine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Colchicine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Colchicine Revenue Market Share by Region (2021-2026) Table 62. Global Colchicine Revenue Market Share by Region (2027-2032) Table 63. Yunnan Plant Medicine Company Information Table 64. Yunnan Plant Medicine Business Overview Table 65. Yunnan Plant Medicine Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yunnan Plant Medicine Colchicine Product Portfolio Table 67. Yunnan Plant Medicine Recent Development Table 68. Xishuangbanna Pharmaceutical Company Information Table 69. Xishuangbanna Pharmaceutical Business Overview Table 70. Xishuangbanna Pharmaceutical Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xishuangbanna Pharmaceutical Colchicine Product Portfolio Table 72. Xishuangbanna Pharmaceutical Recent Development Table 73. Takeda Pharmaceuticals Company Information Table 74. Takeda Pharmaceuticals Business Overview Table 75. Takeda Pharmaceuticals Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Takeda Pharmaceuticals Colchicine Product Portfolio Table 77. Takeda Pharmaceuticals Recent Development Table 78. Tonghua Limin Company Information Table 79. Tonghua Limin Business Overview Table 80. Tonghua Limin Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tonghua Limin Colchicine Product Portfolio Table 82. Tonghua Limin Recent Development Table 83. Kunming Pharmaceutical Company Information Table 84. Kunming Pharmaceutical Business Overview Table 85. Kunming Pharmaceutical Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Kunming Pharmaceutical Colchicine Product Portfolio Table 87. Kunming Pharmaceutical Recent Development Table 88. Beijing Jialin Pharmaceutical Company Information Table 89. Beijing Jialin Pharmaceutical Business Overview Table 90. Beijing Jialin Pharmaceutical Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Beijing Jialin Pharmaceutical Colchicine Product Portfolio Table 92. Beijing Jialin Pharmaceutical Recent Development Table 93. Yunnan Shan State Company Information Table 94. Yunnan Shan State Business Overview Table 95. Yunnan Shan State Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Yunnan Shan State Colchicine Product Portfolio Table 97. Yunnan Shan State Recent Development Table 98. Wockhardt Company Information Table 99. Wockhardt Business Overview Table 100. Wockhardt Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Wockhardt Colchicine Product Portfolio Table 102. Wockhardt Recent Development Table 103. West-Ward Company Information Table 104. West-Ward Business Overview Table 105. West-Ward Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. West-Ward Colchicine Product Portfolio Table 107. West-Ward Recent Development Table 108. Rhea Pharmaceutical Company Information Table 109. Rhea Pharmaceutical Business Overview Table 110. Rhea Pharmaceutical Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Rhea Pharmaceutical Colchicine Product Portfolio Table 112. Rhea Pharmaceutical Recent Development Table 113. Prasco Company Information Table 114. Prasco Business Overview Table 115. Prasco Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Prasco Colchicine Product Portfolio Table 117. Prasco Recent Development Table 118. Odan Laboratories Company Information Table 119. Odan Laboratories Business Overview Table 120. Odan Laboratories Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Odan Laboratories Colchicine Product Portfolio Table 122. Odan Laboratories Recent Development Table 123. Medinova Company Information Table 124. Medinova Business Overview Table 125. Medinova Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Medinova Colchicine Product Portfolio Table 127. Medinova Recent Development Table 128. Hikma Company Information Table 129. Hikma Business Overview Table 130. Hikma Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hikma Colchicine Product Portfolio Table 132. Hikma Recent Development Table 133. Guangdong Pedi Company Information Table 134. Guangdong Pedi Business Overview Table 135. Guangdong Pedi Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Guangdong Pedi Colchicine Product Portfolio Table 137. Guangdong Pedi Recent Development Table 138. Excellium Pharmaceutical Company Information Table 139. Excellium Pharmaceutical Business Overview Table 140. Excellium Pharmaceutical Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Excellium Pharmaceutical Colchicine Product Portfolio Table 142. Excellium Pharmaceutical Recent Development Table 143. Cipla Company Information Table 144. Cipla Business Overview Table 145. Cipla Colchicine Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Cipla Colchicine Product Portfolio Table 147. Cipla Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Colchicine Distributors List Table 151. Colchicine Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Colchicine Product Image Figure 2. Global Colchicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Colchicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Colchicine Sales (2021-2032) & (tons) Figure 5. Global Colchicine Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Colchicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Oral Solution Image Figure 10. Global Colchicine Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 11. Global Colchicine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Colchicine Sales Market Share by Type (2021-2032) Figure 13. Global Colchicine Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Colchicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Colchicine Revenue Market Share by Type (2021-2032) Figure 16. Acute Gout Image Figure 17. Chronic Gout Image Figure 18. Other Conditions Image Figure 19. Global Colchicine Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Colchicine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Colchicine Sales Market Share by Application (2021-2032) Figure 22. Global Colchicine Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Colchicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Colchicine Revenue Market Share by Application (2021-2032) Figure 25. North America Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 26. North America Colchicine Sales Market Share by Country (2021-2032) Figure 27. U.S. Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 28. Canada Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 29. Mexico Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 30. Europe Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 31. Europe Colchicine Sales Market Share by Country (2021-2032) Figure 32. Germany Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 33. France Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 34. U.K. Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 35. Italy Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 36. Netherlands Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 37. Asia Pacific Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 38. Asia Pacific Colchicine Sales Market Share by Country (2021-2032) Figure 39. China Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 40. Japan Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 41. South Korea Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 42. Southeast Asia Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 43. India Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 44. Australia Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 45. South America, Middle East and Africa Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 46. South America, Middle East and Africa Colchicine Sales Market Share by Country (2021-2032) Figure 47. Brazil Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 48. South Africa Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 49. Saudi Arabia Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 50. Turkey Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 51. Argentina Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 52. UAE Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 53. Egypt Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 54. Chile Colchicine Sales and Growth Rate (2021-2032) & (tons) Figure 55. Global Colchicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Colchicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Colchicine Revenue (2021-2032) & (US$ Million) Figure 58. North America Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Colchicine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Colchicine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Colchicine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Colchicine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Colchicine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Acute Gout
  • Chronic Gout
  • Other Conditions
Companies covered
  • Yunnan Plant Medicine
  • Xishuangbanna Pharmaceutical
  • Takeda Pharmaceuticals
  • Tonghua Limin
  • Kunming Pharmaceutical
  • Beijing Jialin Pharmaceutical
  • Yunnan Shan State
  • Wockhardt
  • West-Ward
  • Rhea Pharmaceutical
  • Prasco
  • Odan Laboratories
  • Medinova
  • Hikma
  • Guangdong Pedi
  • Excellium Pharmaceutical
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Colchicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Colchicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Colchicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Colchicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Colchicine Market Dynamics
  1. 2.1 Colchicine Industry Trends
  2. 2.2 Colchicine Industry Drivers
  3. 2.3 Colchicine Industry Opportunities and Challenges
  4. 2.4 Colchicine Industry Restraints
3 Colchicine Market by Manufacturers
  1. 3.1 Global Colchicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Colchicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Colchicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Colchicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Colchicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Colchicine Manufacturers, Product Type & Application
  7. 3.7 Global Colchicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Colchicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Colchicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Colchicine Tier 1, Tier 2, and Tier 3
4 Colchicine Market by Type
  1. 4.1 Colchicine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Solution
  4. 4.2 Global Colchicine Sales by Type
  5. 4.2.1 Global Colchicine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Colchicine Sales by Type (2021-2032)
  7. 4.2.3 Global Colchicine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Colchicine Revenue by Type
  9. 4.3.1 Global Colchicine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Colchicine Revenue by Type (2021-2032)
  11. 4.3.3 Global Colchicine Revenue Market Share by Type (2021-2032)
5 Colchicine Market by Application
  1. 5.1 Colchicine Application Introduction
  2. 5.1.1 Acute Gout
  3. 5.1.2 Chronic Gout
  4. 5.1.3 Other Conditions
  5. 5.2 Global Colchicine Sales by Application
  6. 5.2.1 Global Colchicine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Colchicine Sales by Application (2021-2032)
  8. 5.2.3 Global Colchicine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Colchicine Revenue by Application
  10. 5.3.1 Global Colchicine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Colchicine Revenue by Application (2021-2032)
  12. 5.3.3 Global Colchicine Revenue Market Share by Application (2021-2032)
6 Global Colchicine Sales by Region
  1. 6.1 Global Colchicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Colchicine Sales by Region (2021-2032)
  3. 6.2.1 Global Colchicine Sales by Region (2021-2026)
  4. 6.2.2 Global Colchicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Colchicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Colchicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Colchicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Colchicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Colchicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Colchicine Revenue by Region
  1. 7.1 Global Colchicine Revenue by Region
  2. 7.1.1 Global Colchicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Colchicine Revenue by Region (2021-2026)
  4. 7.1.3 Global Colchicine Revenue by Region (2027-2032)
  5. 7.1.4 Global Colchicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Colchicine Revenue (2021-2032)
  8. 7.2.2 North America Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Colchicine Revenue (2021-2032)
  11. 7.3.2 Europe Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Colchicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Colchicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Colchicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunnan Plant Medicine
  2. 8.1.1 Yunnan Plant Medicine Company Information
  3. 8.1.2 Yunnan Plant Medicine Business Overview
  4. 8.1.3 Yunnan Plant Medicine Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yunnan Plant Medicine Colchicine Product Portfolio
  6. 8.1.5 Yunnan Plant Medicine Recent Developments
  7. 8.2 Xishuangbanna Pharmaceutical
  8. 8.2.1 Xishuangbanna Pharmaceutical Company Information
  9. 8.2.2 Xishuangbanna Pharmaceutical Business Overview
  10. 8.2.3 Xishuangbanna Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xishuangbanna Pharmaceutical Colchicine Product Portfolio
  12. 8.2.5 Xishuangbanna Pharmaceutical Recent Developments
  13. 8.3 Takeda Pharmaceuticals
  14. 8.3.1 Takeda Pharmaceuticals Company Information
  15. 8.3.2 Takeda Pharmaceuticals Business Overview
  16. 8.3.3 Takeda Pharmaceuticals Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceuticals Colchicine Product Portfolio
  18. 8.3.5 Takeda Pharmaceuticals Recent Developments
  19. 8.4 Tonghua Limin
  20. 8.4.1 Tonghua Limin Company Information
  21. 8.4.2 Tonghua Limin Business Overview
  22. 8.4.3 Tonghua Limin Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tonghua Limin Colchicine Product Portfolio
  24. 8.4.5 Tonghua Limin Recent Developments
  25. 8.5 Kunming Pharmaceutical
  26. 8.5.1 Kunming Pharmaceutical Company Information
  27. 8.5.2 Kunming Pharmaceutical Business Overview
  28. 8.5.3 Kunming Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kunming Pharmaceutical Colchicine Product Portfolio
  30. 8.5.5 Kunming Pharmaceutical Recent Developments
  31. 8.6 Beijing Jialin Pharmaceutical
  32. 8.6.1 Beijing Jialin Pharmaceutical Company Information
  33. 8.6.2 Beijing Jialin Pharmaceutical Business Overview
  34. 8.6.3 Beijing Jialin Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Jialin Pharmaceutical Colchicine Product Portfolio
  36. 8.6.5 Beijing Jialin Pharmaceutical Recent Developments
  37. 8.7 Yunnan Shan State
  38. 8.7.1 Yunnan Shan State Company Information
  39. 8.7.2 Yunnan Shan State Business Overview
  40. 8.7.3 Yunnan Shan State Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Yunnan Shan State Colchicine Product Portfolio
  42. 8.7.5 Yunnan Shan State Recent Developments
  43. 8.8 Wockhardt
  44. 8.8.1 Wockhardt Company Information
  45. 8.8.2 Wockhardt Business Overview
  46. 8.8.3 Wockhardt Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Wockhardt Colchicine Product Portfolio
  48. 8.8.5 Wockhardt Recent Developments
  49. 8.9 West-Ward
  50. 8.9.1 West-Ward Company Information
  51. 8.9.2 West-Ward Business Overview
  52. 8.9.3 West-Ward Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 West-Ward Colchicine Product Portfolio
  54. 8.9.5 West-Ward Recent Developments
  55. 8.10 Rhea Pharmaceutical
  56. 8.10.1 Rhea Pharmaceutical Company Information
  57. 8.10.2 Rhea Pharmaceutical Business Overview
  58. 8.10.3 Rhea Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Rhea Pharmaceutical Colchicine Product Portfolio
  60. 8.10.5 Rhea Pharmaceutical Recent Developments
  61. 8.11 Prasco
  62. 8.11.1 Prasco Company Information
  63. 8.11.2 Prasco Business Overview
  64. 8.11.3 Prasco Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Prasco Colchicine Product Portfolio
  66. 8.11.5 Prasco Recent Developments
  67. 8.12 Odan Laboratories
  68. 8.12.1 Odan Laboratories Company Information
  69. 8.12.2 Odan Laboratories Business Overview
  70. 8.12.3 Odan Laboratories Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Odan Laboratories Colchicine Product Portfolio
  72. 8.12.5 Odan Laboratories Recent Developments
  73. 8.13 Medinova
  74. 8.13.1 Medinova Company Information
  75. 8.13.2 Medinova Business Overview
  76. 8.13.3 Medinova Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medinova Colchicine Product Portfolio
  78. 8.13.5 Medinova Recent Developments
  79. 8.14 Hikma
  80. 8.14.1 Hikma Company Information
  81. 8.14.2 Hikma Business Overview
  82. 8.14.3 Hikma Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hikma Colchicine Product Portfolio
  84. 8.14.5 Hikma Recent Developments
  85. 8.15 Guangdong Pedi
  86. 8.15.1 Guangdong Pedi Company Information
  87. 8.15.2 Guangdong Pedi Business Overview
  88. 8.15.3 Guangdong Pedi Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guangdong Pedi Colchicine Product Portfolio
  90. 8.15.5 Guangdong Pedi Recent Developments
  91. 8.16 Excellium Pharmaceutical
  92. 8.16.1 Excellium Pharmaceutical Company Information
  93. 8.16.2 Excellium Pharmaceutical Business Overview
  94. 8.16.3 Excellium Pharmaceutical Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Excellium Pharmaceutical Colchicine Product Portfolio
  96. 8.16.5 Excellium Pharmaceutical Recent Developments
  97. 8.17 Cipla
  98. 8.17.1 Cipla Company Information
  99. 8.17.2 Cipla Business Overview
  100. 8.17.3 Cipla Colchicine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cipla Colchicine Product Portfolio
  102. 8.17.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Colchicine Value Chain Analysis
  2. 9.1.1 Colchicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Colchicine Production Mode & Process
  6. 9.2 Colchicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Colchicine Distributors
  9. 9.2.3 Colchicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research